Joined Cambium August 2013. President, CEO of 3Ti (automated blood analyzer start-up) 2006-16.   CEO of Refocus Group (ophthalmic device start-up) 2002-05. CMO of Autonomous Technologies (refractive surgery start-up) from 1994-98.   SVP-Sales & Marketing and Business Development at CIBA Vision (Novartis) 1988-98. Director VirtualScopics (public medical imaging software company) 2006-16. BS-Indiana, MBA-Notre Dame.

Professor of Medicine, Pathology & Hematology/Oncology, Associate Director Winship Cancer Institute, Director of Division of Stem Cell Transplantation & Immunotherapy and Bone Marrow & Stem Cell Transplant Centers, Medical Director of Center for Apheresis and Stem Cell Processing Lab—all at Emory University. BS-Harvard, MD-Cornell, PhD-Rockefeller University.

Director Center for Transfusion & Cellular Therapies, Medical Director Emory University Hospital Blood Bank & Emory Healthcare School of Medical Technology. Co-author of leading text book in Transfusion Medicine. Chief Scientific Advisor, Co-Founder of 3Ti (automated blood analyzer) 2000-16. Has authored, co-authored numerous NIH STTR and DOD grants. National Blood Foundation Scholar. BS-Johns Hopkins, MD & PhD-Chicago.

Spent 15 years in medical research, primarily cellular therapies. Assistant Professor of Medicine, Hematology & Lab Director Personalized Immunotherapy Center, Emory University. Faculty Member Parker H. Petit Institute for Bioengineering & Bioscience at Georgia Tech. Director of Regenerative Medicine at AccelLAB 2008-10. 20 published papers. PhD-University of Toronto. 1973-2015.